Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects

https://doi.org/10.1016/j.jchromb.2010.05.012Get rights and content

Abstract

Background

Exhaled breath condensate collection is a non-invasive method of sampling the respiratory tract that can be repeated several times in a wide range of clinical settings. Quantitation of non-volatile compounds in the condensate requires highly sensitive analytical methods, e.g. mass spectrometry.

Objective

To validate cross-platform measurements of eicosanoids using high performance liquid chromatography or gas chromatography coupled with mass spectrometry in exhaled breath condensate sampled from 58 healthy individuals.

Methods

Twenty different eicosanoid compounds, representing major arachidonic acid lipoxygenation and cyclooxygenation pathways were measured using a stable isotope dilution method. We applied a free palmitic acid concentration as a surrogate marker for the condensate dilution factor.

Results

Eicosanoids concentrations in the condensates were consistent with their content in other biological fluids. Prostaglandin E2 was the most abundant mediator, represented by its stable metabolite tetranor-PGEM. Prostaglandin D2 products were at low concentration, while hydroxyacids derived from lipoxygenation were abundant. 5-HETE was elevated in current tobacco smokers. Leukotriene B4 has the highest concentration of all 5-LO products. 15-LO analogues of cysteinyl leukotrienes–eoxins were detectable and metabolized to eoxin E4. Two main vascular prostanoids: prostacyclin and thromboxane B2 were present as metabolites. A marker for non-enzymatic lipid peroxidation, 8-iso-PGF isoprostane was increased in smokers.

Conclusion

Presented targeted lipidomics analysis of exhaled breath condensate in healthy subjects justifies its application to investigation of inflammatory lung diseases. Measurements of non-volatile mediators of inflammation in the condensates might characterize disease-specific pathological mechanisms and responses to treatment.

Introduction

Breath, in several cultures, has been a primordial substance associated with origin of life, as well as life's essential manifestation. Yet in medicine, assessment of chemistry of breath has begun only recently. It came about well over 100 years after the atmospheric air was liquefied [1] and has been based on a similar principle of cooling breath into a liquid state. Thus, in commercial or custom-made devices, during tidal breathing, exhaled air is directed through the one-way inspiratory valve to a cooling trap, resulting in accumulation of a clear liquid. About 99% of it consists of water, but the remaining 1% is of utmost interest [2]. This tiny fraction is composed of both volatile and non-volatile compounds that include several biomarkers. Their origin is not clear. It is assumed that they are present in the liquid lining of the airway surface; they become aerolized and carried up during turbulent airflow.

Exhaled breath condensate (EBC) is of great interest to clinicians. Its collection is a completely non-invasive method of sampling of the respiratory tract that can be repeated several times. Collection devices are portable and can be used in a wide range of settings, including outpatient clinics, intensive care units, workplaces, and at home. The method offers a new insight into pathology of respiratory tract and holds promise for clinical utility. Still, unresolved questions remain, especially sensitivity of the assay techniques (ELISA in most studies) for many biomarkers, contributing to the reported variability [3]. This is particularly true for lipids, present in very low concentrations in EBC. Yet, their role as signaling and inflammatory molecules is being recognized.

Mass spectrometry occupies a leading position in the characterization, identification and quantitation of lipids. Its use has led to emergence of lipidomics, defined as the large-scale study of cellular lipids [4], [5], [6], [7] (i.e. the lipidome). Mass spectrometry was applied sporadically for measurement of single lipid mediators in EBC [8]. Here we present high performance liquid chromatography–tandem mass spectrometry (HPLC–MS2) and gas chromatography–mass spectrometry (GC–MS) techniques focused on the “targeted” lipidomic analysis of multiple derivatives of arachidonic acid.

Section snippets

EBC collection

In a pilot study we compared the results of cys-LTs determination in EBC obtained with two instruments: ECO Screen I and II, both products of Jeager (GmbH Hoechberg, Germany). The measurements were substantially lower with the use of the later than the former device. This was due to adsorption of eicosanoids to large surface of plastic bags present in ECO Screen II, but not I, as already noticed by Tufvesson [9]. Therefore, all further experiments were carried out with ECO Screen I. EBC was

Calculation

Concentration of measured compounds, quantified using a stable isotope dilution method, are presented as medians with the ranges from 25 to 75 centiles. Departure from normal distribution was tested using Shapiro–Wilk statistics. Correlation analyses were performed using Spearman's rank test. Between the groups comparisons were done using non-parametric Mann–Whitney test. Principal component analysis was done with the normally distributed concentrations of eicosanoids and palmitic acid. All

Results

Medians and inter-quartiles ranges of the measured compounds are presented in Table 4.

Statistical analysis of raw data distinguished the metabolites, with normal distribution in EBC samples: PA, LXA4, 11-dehydro-TXB2, 6-keto-PGF, and EXC4, while the remaining metabolites distribution suggested a greater inter-individual variation. The most abundant eicosanoids in EBC were tetranor-PGEM, 6-keto-PGF, LTB4 and 11-dehydro-TXB2. There was a highly significant positive correlation between PA and

Discussion

The aim of the current study was to develop an analytical approach based on mass spectrometry measurements of eicosanoids of healthy subjects in EBC. Due to the extremely low concentrations in EBC, close to detection threshold of immunoenzymatic assays (∼7.5 pg/mL), and a small sample volume, quantitative analysis of eicosanoids is very limited [9]. Fast non-invasive method of collection and ability to repeat sampling gives EBC an advantage over induced sputum or bronchoalveolar lavage.

Acknowledgments

This work was supported by the grants from EEA Financial Mechanism and from the Foundation for Advancement of Polish Pharmacy and Science.

References (21)

  • Y. Kita et al.

    Anal. Biochem.

    (2005)
  • A.D. Postle et al.

    J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.

    (2009)
  • P. Montuschi

    J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.

    (2009)
  • E. Tufvesson

    L. Respir. Med.

    (2006)
  • C.N. Serhan

    Prostaglandins Other Lipids Mediat.

    (2005)
  • R.C. Murphy et al.

    Anal. Biochem.

    (2005)
  • D. Tsikas

    J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.

    (1998)
  • A. Mehta et al.

    J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.

    (1998)
  • H. Ronni-Sivula et al.

    Prostaglandins

    (1993)
  • S. Wróblewski et al.

    Paris Acad. Sci. Compt. Rend.

    (1883)
There are more references available in the full text version of this article.

Cited by (58)

  • Molecularly imprinted polymer based-solid phase extraction combined with dispersive liquid–liquid microextraction using new deep eutectic solvent; selective extraction of valproic acid from exhaled breath condensate samples

    2021, Microchemical Journal
    Citation Excerpt :

    EBC is a complex matrix which is composed of different chemical compounds such as volatile or non-volatile biomolecules, proteins, lipids, carbohydrates, and drugs [6–10]. Some compounds including hydrogen peroxide [11], nitric oxide [12], eicosanoids [13], pesticides [14], aldehydes [9], and amino acids [10] have been monitored in EBC samples. Valproic acid (VPA) is a known drug applied to treat bipolar disorders, epilepsy, migraine headaches [15], and a variety of cancers due to its anti-proliferative effects [16,17].

  • Development of an accurate and sensitive method for lactate analysis in exhaled breath condensate by LC MS/MS

    2017, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
  • Eosinophil production of prostaglandin D<inf>2</inf> in patients with aspirin-exacerbated respiratory disease

    2016, Journal of Allergy and Clinical Immunology
    Citation Excerpt :

    Although contributing to many of the untoward effects of AERD, as evinced by the beneficial effects of LT modifiers,29 increasing attention has been given to contributions from PGD2. PGD2 and its metabolites are higher at baseline in patients with AERD subjects in comparison with aspirin-tolerant subjects.30,31 Among the patients with AERD, there exists a subgroup with particularly enhanced overproduction and release of PGD2 during aspirin challenge that correlates with the severity of AERD and predicts failure of aspirin desensitization.6

View all citing articles on Scopus
View full text